Phytochem Remedies (India) Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 3.15 Cr
as on 24-10-2024
- Company Age 22 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.80 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.27 Cr
as on 24-10-2024
- Revenue 49.58%
(FY 2023)
- Profit 57.39%
(FY 2023)
- Ebitda 203.18%
(FY 2023)
- Net Worth 16.04%
(FY 2023)
- Total Assets 72.24%
(FY 2023)
About Phytochem Remedies (India)
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.15 Cr.
The company currently has active open charges totaling ₹24.80 Cr. The company has closed loans amounting to ₹4.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Niranjan Surana and Aditi Bohra serve as directors at the Company.
- CIN/LLPIN
U24233RJ2002PTC017943
- Company No.
017943
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Phytochem Remedies (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditi Bohra  | Director | 20-May-2019 | Current |
| Niranjan Surana | Director | 01-Oct-2009 | Current |
Financial Performance of Phytochem Remedies (India).
Phytochem Remedies (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.58% increase. The company also saw a substantial improvement in profitability, with a 57.39% increase in profit. The company's net worth Soared by an impressive increase of 16.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phytochem Remedies (India)?
In 2023, Phytochem Remedies (India) had a promoter holding of 17.87% and a public holding of 82.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bohra Agrifilms Private LimitedActive 25 years 9 monthsNiranjan Surana and Aditi Bohra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Mar 2024 | ₹1.00 Cr | Open |
Others Creation Date: 31 Mar 2023 | ₹4.80 Cr | Open |
Others Creation Date: 30 Mar 2022 | ₹15.00 Cr | Open |
How Many Employees Work at Phytochem Remedies (India)?
Unlock and access historical data on people associated with Phytochem Remedies (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phytochem Remedies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phytochem Remedies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
